期刊文献+

表观遗传学在肺癌诊治中的研究进展 被引量:10

Research situation of epigenetic modification in lung cancer diagnosis
原文传递
导出
摘要 目的:总结表观遗传学在肺癌诊疗中的研究现状,探讨表观遗传学在肺癌临床工作中的应用和前景。方法:应用Medline、PubMed及CNKI期刊全文数据库检索系统,以"表观遗传学、肺癌"等为关键词,检索2005-01-2011-12的相关文献,共检索到英文文献616条,中文文献53条。纳入标准:1)表观遗传学与肺癌的分类和早期诊断的关系;2)表观遗传学预测肺癌的转移复发;3)表观遗传学在肺癌治疗中的应用;4)表观遗传学对常规放疗、化疗的影响。根据纳入标准,符合分析的文献22篇。结果:表观遗传修饰,如DNA甲基化、组蛋白乙酰化和甲基化、RNA相关性沉默等,与细胞生长、分化、凋亡、转化及肿瘤进展相关基因的转录密切相关。肺癌的发生和发展与表观遗传修饰异常直接相关。结论:表观遗传学与肿瘤的诊断、分期、进展和预后密切相关,从而为肺癌的基因诊断和治疗提供了新的思路和手段。 OBJECTIVE: To summarize the present research situation of epigenetic modification in lung cancer diagnosis and discuss the application and prospect of epigenetic modification in clinical work of lung cancer.METHODS: To retrieval the articles on epigenetic study from 2005 to 2011 by PubMed,Medline and CNKI full-text database retrieval system with "epigenetic,cancer" as Keywords and get at all 616 English articles and 53 Chinese ones.Selection standard: 1) The relations of epigenetics with classification and early diagnosis of lung cancer;2) the prediction of metastasis and recurrence of lung cancer by epigenetics;3) the application of epigenetics in treating lung cancer,4) the influence of epigenetics on conventional radiation and chemotherapy.According to the selection standard there are 22 articles to meet the requirement.RESULTS: Epigenetic modification,such as DNA methylation,acetylation and methylation of histone and RNA correlation silence,relates closely with the growth-differentiation-apoptosis-transformation of cells and tumor-progression-related gene transcription.The occurrence and development of lung cancer relates directly epigenetic modification abnormal.CONCLUSIONS:Epigenetic modification is so closely related with diagnosis-classification-development of cancer that the new ideas and methods are provided for the gene diagnosis and treatment of lung cancer.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第2期150-153,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 肺肿瘤 表观遗传修饰 表观遗传学 综述文献 lung neoplasms epigenetic modification epigenetics literature review
  • 相关文献

参考文献3

二级参考文献59

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献986

同被引文献103

  • 1李改,鞠晓红,易书英,戚新元.超声引导下经皮穿刺在胸部疑难病灶中的应用[J].中国超声诊断杂志,2006,7(7):504-506. 被引量:4
  • 2邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:152
  • 3肯普H.科恩斯坦,卡伦L.瑞凯姆.肺癌一多学科诊断与治疗的探索[M].许顺主译.沈阳:辽宁科学技术出版社,2012:1.
  • 4NCCN. The NCCN Non-small cell lung cancer clinical practice guide-lines in oncology (version 2. 2012)EEB/OL]. Fort Washington~ NC- CN,2011[2011-10-04-]. http:www, nccn. org/professionals/physician _gls/f_guidelines. asp # nscl.
  • 5Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage I non- small cell lung cancer[J]. J Clin Oncol, 2003,21 (6) : 1029-1034.
  • 6Doddoli C, Aragon A, Barlesi F, et al. Does the extent of lymph node dissection influence outcome in patients with stage I non- small cell lung cancer? [J]. Eur J Cardiothorac Surg, 2005,27 (4) :680-685.
  • 7Wu YC, Lin CF, Hsu WH, et al. Long-term results of pathologi- cal stage I non-small cell lung cancer: validation of using the number of totally removed lymph nodes as a staging control[J]. Eur J Cardiothorac Surg, 2003,24(6) : 994-1001.
  • 8Varlotto JM,Reeht A, Nikolov M, et al. Extent of lymphadenec- tomy and outcome for patients with stage I non-small cell lung cancer[J]. Cancer, 2009,115 (4) : 851-858.
  • 9Sato K,Tomaizawa Y, Lijima H,et al. Epigenetic inactivation ofthe RUNX3 gene in lung cancer [J], Oncol Rep, 2006, 15(1):129-135.
  • 10Torquati A,0,rear L, Longobardi L,et al. RUNX3 inhibits cellproliferation and induces apoptosis by reinstating transforminggrowth factor beta responsiveness in esophageal adenocarcinomacells[J]. Surg,2004,136(2) :310-316.

引证文献10

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部